Trial design, submission, ethics, governance, recruitment, completion.... absolutely not happening in 2-3 months.
Best case for approval would be under 2 years.
Two separate trials look to be required as well.
I believe this is a great drug & product.
Management have been disingenuous with shareholders.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.010(3.51%) |
Mkt cap ! $30.78M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 27.5¢ | $91.28K | 329.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 88373 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 58024 | 4 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |